Overview of the use of recombinant factor VIIa in children
John Puetz Department of Pediatrics, Division of Hematology/Oncology, Cardinal Glennon Children's Medical Center, Saint Louis University, St Louis, MO, USA Abstract: Recombinant factor VIIa (rFVIIa) was initially developed as a bypassing agent to control bleeding in people with hemophilia...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-10-01
|
| Series: | Pediatric Health, Medicine and Therapeutics |
| Online Access: | http://www.dovepress.com/overview-of-the-use-of-recombinant-factor-viia-in-children-peer-reviewed-article-PHMT |